| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,099 | 4,302 | 8,226 | 9,334 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 3,099 | 4,302 | 8,226 | 9,334 | | | Operating Expenses | | Research Development | 12,188 | 11,663 | 9,493 | 12,888 | | Selling General and Administrative | 3,592 | 3,458 | 3,243 | 3,521 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,681) | (10,819) | (4,510) | (7,075) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 144 | (8) | (100) | (129) | | Earnings Before Interest And Taxes | (12,537) | (10,827) | (4,610) | (7,204) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (12,537) | (10,827) | (4,610) | (7,204) | | Income Tax Expense | (162) |
-
|
-
| (101) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,375) | (10,827) | (4,610) | (7,103) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,375) | (10,827) | (4,610) | (7,103) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,375) | ($10,827) | ($4,610) | ($7,103) |
|
1.23% Nasdaq 
Income Statement
